Bone mass evolution after renal transplantation.
E
E
Goffin
J P
JP
Devogelaer
G
G
Depresseux
C
C
van Ypersele de Strihou
D001851:Bone Diseases, Metabolic / Q000139:chemically induced / Q000517:prevention & control*; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000009:adverse effects*; D013256:Steroids / Q000009:adverse effects / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D013256:Steroids; D016572:Cyclosporine